Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer
- Author
- A Debucquoy, K Haustermans, A Daemen, S Aydin, Louis Libbrecht (UGent) , O Gevaert, B De Moor, S Tejpar, WH McBride, F Penninckx, P Scalliet, C Stroh, S Vlassak, C Sempoux and JP Machiels
- Organization
- Keywords
- EXPRESSION, RADIOTHERAPY, PHASE-II TRIAL, PREDICTS SURVIVAL, SQUAMOUS-CELL CARCINOMA, GROWTH-FACTOR-RECEPTOR, METASTATIC COLORECTAL-CANCER, RADIOCHEMOTHERAPY, MULTICENTER, CHEMOTHERAPY
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-903860
- MLA
- Debucquoy, A., et al. “Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 27, no. 17, AMER SOC CLINICAL ONCOLOGY, 2009, pp. 2751–57, doi:10.1200/JCO.2008.18.5033.
- APA
- Debucquoy, A., Haustermans, K., Daemen, A., Aydin, S., Libbrecht, L., Gevaert, O., … Machiels, J. (2009). Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer. JOURNAL OF CLINICAL ONCOLOGY, 27(17), 2751–2757. https://doi.org/10.1200/JCO.2008.18.5033
- Chicago author-date
- Debucquoy, A, K Haustermans, A Daemen, S Aydin, Louis Libbrecht, O Gevaert, B De Moor, et al. 2009. “Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer.” JOURNAL OF CLINICAL ONCOLOGY 27 (17): 2751–57. https://doi.org/10.1200/JCO.2008.18.5033.
- Chicago author-date (all authors)
- Debucquoy, A, K Haustermans, A Daemen, S Aydin, Louis Libbrecht, O Gevaert, B De Moor, S Tejpar, WH McBride, F Penninckx, P Scalliet, C Stroh, S Vlassak, C Sempoux, and JP Machiels. 2009. “Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer.” JOURNAL OF CLINICAL ONCOLOGY 27 (17): 2751–2757. doi:10.1200/JCO.2008.18.5033.
- Vancouver
- 1.Debucquoy A, Haustermans K, Daemen A, Aydin S, Libbrecht L, Gevaert O, et al. Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer. JOURNAL OF CLINICAL ONCOLOGY. 2009;27(17):2751–7.
- IEEE
- [1]A. Debucquoy et al., “Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer,” JOURNAL OF CLINICAL ONCOLOGY, vol. 27, no. 17, pp. 2751–2757, 2009.
@article{903860, author = {{Debucquoy, A and Haustermans, K and Daemen, A and Aydin, S and Libbrecht, Louis and Gevaert, O and De Moor, B and Tejpar, S and McBride, WH and Penninckx, F and Scalliet, P and Stroh, C and Vlassak, S and Sempoux, C and Machiels, JP}}, issn = {{0732-183X}}, journal = {{JOURNAL OF CLINICAL ONCOLOGY}}, keywords = {{EXPRESSION,RADIOTHERAPY,PHASE-II TRIAL,PREDICTS SURVIVAL,SQUAMOUS-CELL CARCINOMA,GROWTH-FACTOR-RECEPTOR,METASTATIC COLORECTAL-CANCER,RADIOCHEMOTHERAPY,MULTICENTER,CHEMOTHERAPY}}, language = {{eng}}, location = {{Chicago, IL}}, number = {{17}}, pages = {{2751--2757}}, publisher = {{AMER SOC CLINICAL ONCOLOGY}}, title = {{Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer}}, url = {{http://doi.org/10.1200/JCO.2008.18.5033}}, volume = {{27}}, year = {{2009}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: